Loading organization details...
Loading organization details...
GENERATE IDEAS, PRODUCE EVIDENCE, AND DESIGN SOLUTIONS TO IMPROVE (SEE SCHEDULE O)
Source: IRS Form 990 (Tax Year 2024)
Source: IRS e-Filed Form 990 (from the IRS e-File system), Tax Year 2024
Total Revenue
▼$53.8M
Program Spending
79%
of total expenses go to program services
Total Contributions
$41.8M
Total Expenses
▼$62.5M
Total Assets
$181.9M
Total Liabilities
▼$51.7M
Net Assets
$130.2M
Officer Compensation
→$2.2M
Other Salaries
$23.1M
Investment Income
$8.1M
Fundraising
▼N/A
Tax Year 2024 · Source: IRS Form 990, Schedule I (Grants and Other Assistance)
Total grants awarded: $919.7K
| Recipient | Location | Amount | Type | Purpose |
|---|---|---|---|---|
TULANE UNIVERSITY72-0423889 | NEW ORLEANS, LA | $500.2K | Cash | SOCIAL & BEHAVIORAL SCIENCE; BIOMEDICAL RESEARCH |
OAK CREST INSTITUTE OF SCIENCE95-4680961 | MONROVIA, CA | $164.8K | Cash | BIOMEDICAL RESEARCH |
SEATTLE CHILDREN'S HOSPITAL91-0564748 | SEATTLE, WA | $110.4K | Cash | BIOMEDICAL RESEARCH |
EMORY UNIVERSITY58-0566256 | ATLANTA, GA | $62.9K | Cash | BIOMEDICAL RESEARCH |
WEILL CORNELL MEDICAL COLLEGE13-1623978 | NEW YORK, NY | $51.2K | Cash | SOCIAL & BEHAVIORAL SCIENCE |
CORNELL UNIVERSITY15-0532082 | ITHACA, NY | $19.9K | Cash | BIOMEDICAL RESEARCH |
LOUISIANA STATE UNIVERSITY72-6000848 | NEW ORLEANS, LA | $5,244 | Cash | BIOMEDICAL RESEARCH |
PATH91-1157127 | SEATTLE, WA | $5,130 | Cash | BIOMEDICAL RESEARCH |
| Total | $919.7K | |||
NEW ORLEANS, LA
$500.2K
MONROVIA, CA
$164.8K
SEATTLE, WA
$110.4K
ATLANTA, GA
$62.9K
NEW YORK, NY
$51.2K
ITHACA, NY
$19.9K
NEW ORLEANS, LA
$5,244
SEATTLE, WA
$5,130
Source: USAspending.gov · Searched by organization name
Total Federal Funding
$510.3M
Awards Found
57
Agency for International Development
$103M
TO PROVIDE INCREMENTAL FUNDING IN THE AMOUNT OF $2,000,000.
Agency for International Development
$55.3M
DIVERSIFICATION OF FAMILY PLANNING ACTIVITIES IN PAKISTAN (DFPAP)
Agency for International Development
$45M
LEADING: LICENSURE AND ENSURING ACCESS TO THE DAPIVIRINE RING (DAPIVRINE RING LAUNCH PROGRAM)
Agency for International Development
$36.4M
PRH/RTU IMPLEMENTATION SCIENCE FOR STRENGTHENING USE OF EVIDENCE (ISSUE)
Agency for International Development
$15.1M
DELIVERING A FAMILY OF CONTRACEPTIVE VAGINAL RINGS
Department of Health and Human Services
$14.6M
COOPORATIVE CONTRACEPTIVE RESEARCH CENTER
Agency for International Development
$12.6M
THIS IS A FOLLOW-ON NEW SOLE SOURCE COOPERAIVE AGREEMENT TO POPULATION COUNCIL TO IMPLIMENT A PROGRAM CALLED HIV PREVENTION FOR VULNERABLE ADOLECENT
Department of Health and Human Services
$11.1M
CONTRACEPTION DEVELOPMENT RESEARCH CENTER TO ADVANCE A NOVEL INTRAVAGINAL RING AS A NON-HORMONAL MULTIPURPOSE PREVENTION TECHNOLOGY - OVERALL – ABSTRACT THE OVERARCHING GOAL OF THE POPULATION COUNCIL’S (PC) P50 PROPOSAL IS TO DEVELOP AN INNOVATIVE NON-HORMONAL MULTIPURPOSE PREVENTION TECHNOLOGY (MPT) INTRAVAGINAL RING (IVR) WITH THE POTENTIAL TO IMPROVE THE LIVES OF MILLIONS OF WOMEN GLOBALLY BY COMBATTING THE OVERLAPPING BURDENS OF UNINTENDED PREGNANCY AND SEXUALLY TRANSMITTED INFECTIONS (STIS), INCLUDING HIV. EMERGING DATA INDICATE THAT WOMEN OVERWHELMINGLY PREFER PRODUCTS THAT PREVENT PREGNANCY AND STIS/HIV OVER ONES THAT PREVENT ONLY PREGNANCY OR ONLY STI/HIVS. OUR ‘CZL-IVR’ IS A USER-CONTROLLED 30-DAY IVR CONTAINING THREE ACTIVE PHARMACEUTICAL INGREDIENTS (APIS), COPPER (C), ZINC ACETATE (Z), AND LACTIDE (L) (A LACTIC ACID PRODRUG) THAT TOGETHER HAVE NON-HORMONAL CONTRACEPTIVE AND ANTI-STI/HIV ACTIVITY INCLUDING CHLAMYDIA (CT), GONORRHEA (GC), HSV-2, AND HIV-1. LACTIDE MAINTAINS OPTIMAL VAGINAL PH AND PROVIDES ANTIBACTERIAL, ANTIVIRAL, AND ANTI-BACTERIAL VAGINOSIS (BV) EFFECTS. WE WILL ADVANCE DEVELOPMENT OF OUR CZL-IVR THROUGH IMPLEMENTATION OF THREE INTEGRATED RESEARCH PROJECTS. IN PROJECT 1 WE AIM TO FORMULATE AND MANUFACTURE CZL-IVRS THAT ACHIEVE 30-DAY API DELIVERY, MANUFACTURE AND CHARACTERIZE IN VITRO MECHANICAL PERFORMANCE OF IVRS WITH VARYING DIMENSIONS AND POLYMERS WITH THE SELECTION OF FOUR CANDIDATES WITH A RANGE OF MECHANICAL CHARACTERISTICS TO EVALUATE IN END-USER RESEARCH, AND ESTABLISH GOOD MANUFACTURING PRACTICE (GMP) PRODUCTION FOR NON-MEDICATED RINGS FOR RESEARCH CONDUCTED IN PROJECT 3. IN PROJECT 2 WE AIM TO DEFINE THE OPTIMAL API DELIVERY DOSES OF THE THREE APIS ALONE AND IN COMBINATION, AND TO CONFIRM THE EFFICACY AND SAFETY OF THE PROTOTYPE CZL-IVR BY CONDUCTING ESSENTIAL PRECLINICAL STUDIES INCLUDING IN-VITRO AND IN-VIVO CONTRACEPTIVE EFFICACY AND ANTIMICROBIAL EFFICACY AND TOXICITY STUDIES OF APIS AND OF PROTOTYPE HUMAN-SIZED AND RHESUS MACAQUE-SIZED CZL- IVRS. IN PROJECT 3 WE WILL INFORM CZL-IVR DEVELOPMENT AND THE FIELD MORE BROADLY THROUGH END-USER RESEARCH EMPLOYING NOVEL MIXED METHOD APPROACHES INCLUDING A CONTROLLED SETTING CROSS-OVER STUDY OF THE FOUR SELECTED CANDIDATE NON-MEDICATED IVRS OF VARYING MECHANICAL CHARACTERISTICS, A 30-DAY CONTINUOUS USE STUDY OF A NON- MEDICATED PROTOTYPE IVR WITH AN EMBEDDED TEMPERATURE SENSOR, AND A NATIONAL CROSS-SECTIONAL SURVEY WITH A DISCRETE CHOICE EXPERIMENT (DCE) AND LATENT CLASS ANALYSIS (LCA). THE ADMINISTRATIVE CORE WILL SUPPORT AND SYNERGIZE OUR INTERDISCIPLINARY COLLABORATIVE RESEARCH, PROVIDE SCIENTIFIC, ADMINISTRATIVE, AND OPERATIONAL EXPERTISE AND OVERSIGHT, AND MANAGE ADVISORY COMMITTEES TO ENSURE ADHERENCE TO TIMELINES AND SUCCESS IN ACHIEVING OUR AIMS THROUGH RIGOROUS SCIENCE. OUR P50 CENTER WILL BE A HUB FOSTERING CAREERS OF EARLY STAGE INVESTIGATORS AND INSPIRING MPT PRODUCT DEVELOPMENT THROUGH FELLOWSHIPS AND PILOT PROJECT GRANTS. DRAWING FROM OUR WORLD-CLASS CENTER FOR BIOMEDICAL RESEARCH AND BUILDING ON DECADES OF SUCCESSFUL CONTRACEPTIVE PRODUCT DEVELOPMENT, THE PC’S P50 CENTER WILL CAPITALIZE ON THE RICH, COLLABORATIVE, AND INTERDISCIPLINARY ENVIRONMENT AND THE VAST EXPERIENCE OF THE PC AND OUR PARTNERS TO ADVANCE DEVELOPMENT OF AN INNOVATIVE MPT PRODUCT.
Agency for International Development
$8M
POSTABORTION CARE AND FAMILY PLANNING
Agency for International Development
$6.5M
COMMUNITY BASED HEALTH PLANNING AND SERVICES
Department of Health and Human Services
$6.3M
MODULATING MUCOSAL DCS AND T CELLS TO LIMIT SIV SPREAD
Agency for International Development
$6.3M
SUPPORT AIDS POPULATION AND HEALTH INTEGRATED ASSISTANCE PROGRAM (APHIA II) OPERATIONS RESEARCH PROJECT IN KENYA. THIS IS A THREE-YEAR COOPERATIVE AG
Agency for International Development
$5.3M
TO NEGOTIATE AND AWARD A COOPERATIVE AGREEMENT TO SUPPORT THE DEVELOPMENT IMPLEMENTATION AND SCALING-UP OF COMMUNITY-BASED AGREEMENTS TO DECREASE H
Agency for International Development
$4.8M
THIS MOD ADDS INCREMENTAL FUNDINGS IN THE AMOUNT OF $1,520,000.00
Department of Health and Human Services
$4.7M
AN ETONOGESTREL/ETHINYL ESTRADIOL/QGRIFFITHSIN (ETG/EE/QGRFT) IVR TO PREVENT PREGNANCY AND HIV
Agency for International Development
$4.6M
IMPROVING ACCESS AND DELIVERY OF COMPREHENSIVE POST-EXPOSURE PROPHYLAXIS (PEP) FOR SEXUAL ASSAULT (ADULTS AND CHILDREN) AND OCCUPATIONAL PEP THROUGH
Department of Health and Human Services
$4.5M
NOVEL PRE-COITAL, NON-HORMONAL MULTIPURPOSE PREVENTION TECHNOLOGY (MPT)
Agency for International Development
$4.3M
PRH/RTU-SSR OBJECTIVE 1 - POP COUNCIL
Department of Health and Human Services
$4M
"IMPLEMENTATION OF PROGRAMS FOR PREVENTION, CARE AND TREATMENT OF HIV/AIDS IN THE
Department of Health and Human Services
$3.9M
ROLE OF INTEGRINS IN HIV/SIV TRANSMISSION ACROSS CERVICO-VAGINAL MUCOSA
Department of Health and Human Services
$3.7M
FORMATIVE ASSESSMENT, SIZE ESTIMATION AND INTEGRATED BIOLOGICAL AND BEHAVIORAL SU
Department of Health and Human Services
$3.5M
HIV PREVENTION AND CARE SERVICES FOR YOUNG PEOPLE IN KENYA
Department of Health and Human Services
$3.4M
THE BIOLOGY OF BLOOD-TESTIS BARRIER DYNAMICS
Department of Health and Human Services
$3.3M
EFFECT OF SEX HORMONES ON HIV INFECTION OF CERVICAL AND RECTAL MUCOSAL TISSUE
Department of State
$3.1M
POPULATION COUNCIL PROPOSES TO USE IDR TO COMBAT FORCED BEGGING OF PEOPLE WITH DISABILITIES (PWD) IN ADDIS ABABA, TIGRAY, AND AMHARA, ETHIOPIA.
Department of Health and Human Services
$3.1M
SUPPORTING STRATEGIC PROGRAMMING FOR KEY AND PRIORITY POPULATIONS IN UGANDA THROUGH ENHANCED USE OF DATA
Agency for International Development
$3.1M
INCREMENTAL FUNDING AMOUNT OF $386,000.
Department of Health and Human Services
$3M
ZCM: A NOVEL BROAD-SPECTRUM MICROBICIDE FOR STIS
Department of Health and Human Services
$2.6M
EDUCATION AND HIV RISK AMONG YOUNG PEOPLE IN A HIGH PREVALENCE COUNTRY
Department of Health and Human Services
$2.4M
HIV-ENVELOPE-SPECIFIC DARPIN-BASED MICROBICIDE STRATEGIES
Agency for International Development
$2M
PRH/RTU-SSR OBJECTIVE 3 - POP COUNCIL
Department of Health and Human Services
$1.9M
MODULATING MUCOSAL DCS AND T CELLS TO LIMIT SIV SPREAD
Agency for International Development
$1.8M
SCALING UP POSSIBLE SEVERE BACTERIAL INFECTION (PSBI) GUIDELINES IN KENYA
Agency for International Development
$1.8M
SYYPE 2022 WILL EXAMINE HOW THE LIVES OF THE YOUNG PEOPLE INTERVIEWED IN THE FIRST ROUND OF SYPE 2009 (WHEN THEY WERE AGED 10-29 YEARS) AND RE-INTERVIEWED IN 2014 (WHEN THEY WERE AGED 14-34 YEAR) HAVE CONTINUED TO EVOLVE. THE COHORT IS NOW AGED 22-42 YEARS AND WILL LIKELY HAVE STARTED THEIR OWN FAMILIES. THE MAJORITY WILL HAVE COMPLETED THEIR EDUCATION AND ARE EXPECTED TO BE CONTRIBUTING ECONOMICALLY TO EGYPT. THE THREE MAIN GOALS OF SYPE 2022 ARE: 1. UNDERSTAND THE EFFECTS OF REFORMS AND EVENTS ON VARIOUS GROUPS OF YOUNG PEOPLE; 2. ASSESS THE CURRENT SITUATION OF YOUNG PEOPLE AGED 10-29 WITH REGARD TO HEALTH, EDUCATION, EMPLOYMENT, MARRIAGE AND FAMILY FORMATION, GENDER ATTITUDES, COVID-19, CLIMATE CHANGE; AND, 3. UNDERSTAND TRANSITIONS TO ADULTHOOD AMONGST YOUNG PEOPLE WITH PHYSICAL DISABILITIES AND CHALLENGES AND OPPORTUNITIES THEY HAVE TO FULFILL THEIR FULL POTENTIAL.
Department of Health and Human Services
$1.6M
IMPACT OF ART ON DC AND TEG RESPONSES IN ORAL TISSUES
Department of Health and Human Services
$1.3M
EVALUATION OF A PROGESTERONE VAGINAL RING AS A NEW CONTRACEPTIVE OPTION IN INDIA
Department of Health and Human Services
$1.1M
IN SEARCH OF STEM LEYDIG CELLS: IDENTIFICATION, ISOLATION & DEVELOPMENT
Department of Health and Human Services
$959.3K
AGING AND FUNCTION OF STEM LEYDING CELLS
Department of Health and Human Services
$953K
ROLE OF INTEGRIN A4B7 IN HIV/SIV TRANSMISSION ACROSS CERVICO-VAGINAL MUCOSA
Agency for International Development
$905K
SURVEY OF YOUNG PEOPLE IN EGYPT
Department of Health and Human Services
$899.7K
COMBINING PREP WITH CONTRACEPTION: A PILOT TEST OF AN INTERVENTION TO INCREASE ADHERENCE TO PREP IN ADOLESCENT GIRLS AND YOUNG WOMEN IN ZIMBABWE
Department of Health and Human Services
$862.5K
PARTNERSHIP FOR DEVELOPING BROAD-SPECTRUM MICROBICIDES
Agency for International Development
$732K
PRH/RTU-BIO: POP COUNCIL REGULATORY APPROVAL OF MPTS
Department of Health and Human Services
$424.7K
A NOVEL VAGINAL RING TO PREVENT HIV AND HSV-2 INFECTION, AS WELL AS PREGNANCY
Department of Health and Human Services
$392.9K
ASSESSING & IMPROVING THE MEASUREMENT OF SEXUAL BEHAVIOR
Department of Health and Human Services
$386.4K
ASSESSING WILLINGNESS TO PARTICIPATE AND METHODS FOR IMPROVING ADHERENCE AND SELF
Department of Health and Human Services
$375.9K
ASSESSING THE ACCEPTABILITY, FEASIBILITY, AND A POTENTIAL DISTRIBUTION MODEL OF HIV ORAL SELF-TESTING (HST) AMONG MEN WHO HAVE SEX WITH MEN (MSM) IN
Department of Health and Human Services
$159.9K
ISOLATION AND PROTEOMIC ANALYSIS OF THE SPERM ANNULUS
Department of Health and Human Services
$159.9K
BIOLOGY OF DESMOSOME-GAP JUNCTIONS IN THE TESTIS
Department of Health and Human Services
$144.9K
INTEGRATING 30 YEARS OF SETTLEMENT-LEVEL CENSUS DATA FOR INDIA
Department of Health and Human Services
$135.6K
ACADEMIC SKILLS AND REPRODUCTIVE BEHAVIOR AMONG ADOLESCENT GIRLS.
Department of Health and Human Services
$115.5K
ARE IMPROVEMENTS IN SENESCENT LIFE EXPECTANCY ACCELERATING OR DECELERATING?
Department of Health and Human Services
-$80.2K
GH11-1169: FORMATIVE ASSESSMENT, SIZE ESTIMATION AND INTEGRATED BIOLOGICAL AND BEHAVIORAL SU
Source: Federal Audit Clearinghouse (fac.gov)
Total Audits
9
Clean Audits
8
Material Weakness
Yes
Noncompliance Issues
No
| Year | Status | Financial Report | Federal Expenditure | Low Risk | Accepted |
|---|---|---|---|---|---|
| 2024 | Clean | Unmodified (Clean) | $9.5M | No | 2025-09-30 |
| 2023 | Material Weakness | Unmodified (Clean) | $19.2M | Yes | 2024-12-10 |
| 2022 | Clean | Unmodified (Clean) | $20.4M | Yes | 2023-09-27 |
| 2021 | Clean | Unmodified (Clean) | $15M | Yes | 2022-09-29 |
| 2020 | Clean | Unmodified (Clean) | $17.2M | Yes | 2022-03-30 |
| 2019 | Clean | Unmodified (Clean) | $26.5M | Yes | 2020-09-29 |
| 2018 | Clean | Unmodified (Clean) | $39.2M | Yes | 2019-09-29 |
| 2017 | Clean | Unmodified (Clean) | $37.9M | Yes | 2018-09-26 |
| 2016 | Clean | Unmodified (Clean) | $38.7M | Yes | 2017-07-13 |
Financial Report
Unmodified (Clean)
Federal Expenditure
$9.5M
Financial Report
Unmodified (Clean)
Federal Expenditure
$19.2M
Financial Report
Unmodified (Clean)
Federal Expenditure
$20.4M
Financial Report
Unmodified (Clean)
Federal Expenditure
$15M
Financial Report
Unmodified (Clean)
Federal Expenditure
$17.2M
Financial Report
Unmodified (Clean)
Federal Expenditure
$26.5M
Financial Report
Unmodified (Clean)
Federal Expenditure
$39.2M
Financial Report
Unmodified (Clean)
Federal Expenditure
$37.9M
Financial Report
Unmodified (Clean)
Federal Expenditure
$38.7M
Tax Year 2024 · Source: IRS e-Filed Form 990Schedule J available
Individuals serving as officers, directors, or trustees of the organization.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other |
|---|
Source: IRS Publication 78, Auto-Revocation List & e-Postcard Data
Tax-deductible contributions: Yes
Deductibility code: PC
Sources: IRS e-Filed Form 990 (XML) & ProPublica Nonprofit Explorer
Scroll →
| Year | Revenue | Contributions | Expenses | Assets | Net Assets |
|---|---|---|---|---|---|
| 2024IRS e-File | $53.8M | $41.8M | $62.5M | $181.9M | $130.2M |
| 2023IRS e-File | $67.2M | $47.7M | $79.5M | $177.2M | $132.5M |
| 2022 | $81.6M | $48.7M | $60.5M | $178.2M | $128.2M |
| 2021 | $58.2M |
Sources: ProPublica Nonprofit Explorer & IRS e-File Index
| Tax Year | Form Type | Source | Documents |
|---|---|---|---|
| 2024 | 990 | IRS e-File | PDF not yet published by IRSView Filing → |
| 2023 | 990 | DataIRS e-File | |
| 2022 | 990 | DataIRS e-File |
Financial data: IRS e-Filed Form 990 (Tax Year 2024)
Leadership & compensation: IRS e-Filed Form 990, Part VII (Tax Year 2024)
Federal grants: USAspending.gov (live)
Organization info: IRS Business Master File
Tax-deductibility: IRS Publication 78
| Total |
|---|
| James E Sailer | Vice President & Exec Director, Cbr | 35 | $376.8K | $0 | $67.5K | $444.3K |
| Antony Dutson | Vice President, Cf&a/cfo | 35 | $396.4K | $0 | $41.4K | $437.7K |
| Patricia C Vaughan | Vp, General Counsel & Secretary | 35 | $379.4K | $0 | $42.9K | $422.3K |
| Harriet Birungi | Vp, Int'l Programs (thru 04/24) | 40 | $340.5K | $0 | $8,039 | $348.5K |
| Thoai D Ngo | Vice President, Sbsr (thru 10/24) | 35 | $280.7K | $0 | $37.2K | $317.9K |
| Rana A Hajjeh El-Kebbi | President (beg 09/2024) | 35 | $219.8K | $0 | $4,779 | $224.6K |
James E Sailer
Vice President & Exec Director, Cbr
$444.3K
Hrs/Wk
35
Compensation
$376.8K
Related Orgs
$0
Other
$67.5K
Antony Dutson
Vice President, Cf&a/cfo
$437.7K
Hrs/Wk
35
Compensation
$396.4K
Related Orgs
$0
Other
$41.4K
Patricia C Vaughan
Vp, General Counsel & Secretary
$422.3K
Hrs/Wk
35
Compensation
$379.4K
Related Orgs
$0
Other
$42.9K
Harriet Birungi
Vp, Int'l Programs (thru 04/24)
$348.5K
Hrs/Wk
40
Compensation
$340.5K
Related Orgs
$0
Other
$8,039
Thoai D Ngo
Vice President, Sbsr (thru 10/24)
$317.9K
Hrs/Wk
35
Compensation
$280.7K
Related Orgs
$0
Other
$37.2K
Rana A Hajjeh El-Kebbi
President (beg 09/2024)
$224.6K
Hrs/Wk
35
Compensation
$219.8K
Related Orgs
$0
Other
$4,779
Highest compensated employees who are not officers or directors.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Brid T Devlin | Chief Scientific Officer, Cbr | 35 | $423.1K | $0 | $63.9K | $487K |
| Lisa Haddad | Medical Director | 35 | $320.1K | $0 | $64.5K | $384.6K |
| Jeremy Nuttall | Sr Director, Preclinical Sciences | 35 | $271.6K | $0 |
Brid T Devlin
Chief Scientific Officer, Cbr
$487K
Hrs/Wk
35
Compensation
$423.1K
Related Orgs
$0
Other
$63.9K
Lisa Haddad
Medical Director
$384.6K
Hrs/Wk
35
Compensation
$320.1K
Related Orgs
$0
Other
$64.5K
Jeremy Nuttall
Sr Director, Preclinical Sciences
$339K
Hrs/Wk
35
Compensation
$271.6K
Related Orgs
$0
Other
$67.4K
Members of the governing board. Board members often serve without compensation.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Carmencita Whonder | Trustee | 1 | $0 | $0 | $0 | $0 |
| Darcy Bradbury | Chair Of The Board | 1 | $0 | $0 | $0 | $0 |
| David Serwadda | Trustee | 1 | $0 | $0 | $0 | $0 |
| Edith Asibey | Trustee | 1 | $0 | $0 | $0 | $0 |
| Elizabeth Abrams | Trustee (beg 09/2024) | 1 | $0 | $0 | $0 | $0 |
| Fransje Van Der Waals | Trustee |
Carmencita Whonder
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Darcy Bradbury
Chair Of The Board
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
David Serwadda
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Individuals who previously served as officers or key employees.
| Name | Title | Hrs/Wk | Compensation | Related Orgs | Other | Total |
|---|---|---|---|---|---|---|
| Julia M Bunting Thring | Former President | — | $318K | $0 | $0 | $318K |
Julia M Bunting Thring
Former President
$318K
Hrs/Wk
—
Compensation
$318K
Related Orgs
$0
Other
$0
| $44.8M |
| $61M |
| $168.1M |
| $138.9M |
| 2020 | $57.7M | $43.8M | $61.5M | $165.9M | $131.1M |
| 2019 | $82.6M | $54.2M | $71.1M | $169.9M | $131.9M |
| 2018 | $97.6M | $70M | $82.6M | $145.3M | $106.6M |
| 2017 | $91.4M | $71.8M | $86.7M | $140.9M | $99.6M |
| 2016 | $82.7M | $72.4M | $85.4M | $142.8M | $90.1M |
| 2015 | $79M | $71.4M | $84.2M | $144.9M | $90.6M |
| 2014 | $88.2M | $75.3M | $86.7M | $138.8M | $106.1M |
| 2013 | $81.7M | $74.8M | $87.3M | $139.3M | $109.4M |
| 2012 | $66.1M | $55.2M | $78.4M | $131M | $99.1M |
| 2011 | $70.9M | $59.3M | $85.1M | $135.9M | $103.9M |
| 2021 | 990 | Data |
| 2020 | 990 | Data |
| 2019 | 990 | Data |
| 2018 | 990 | Data |
| 2017 | 990 | Data |
| 2016 | 990 | Data |
| 2015 | 990 | Data |
| 2014 | 990 | Data |
| 2013 | 990 | Data |
| 2012 | 990 | Data |
| 2011 | 990 | Data |
| 2010 | 990 | — |
| 2009 | 990 | — |
| 2008 | 990 | — |
| 2007 | 990 | — |
| 2006 | 990 | — |
| 2005 | 990 | — |
| 2004 | 990 | — |
| 2003 | 990 | — |
| 2002 | 990 | — |
| 2001 | 990 | — |
| $67.4K |
| $339K |
| Bruce Variano | Sr Sci. & Dir Of Cmc | 35 | $260.7K | $0 | $52.6K | $313.3K |
| Anita Garg | Senior Director | 35 | $280.9K | $0 | $24.8K | $305.7K |
Bruce Variano
Sr Sci. & Dir Of Cmc
$313.3K
Hrs/Wk
35
Compensation
$260.7K
Related Orgs
$0
Other
$52.6K
Anita Garg
Senior Director
$305.7K
Hrs/Wk
35
Compensation
$280.9K
Related Orgs
$0
Other
$24.8K
| 1 |
| $0 |
| $0 |
| $0 |
| $0 |
| Georgina Caswell | Trustee | 1 | $0 | $0 | $0 | $0 |
| Indre Rockefeller | Trustee | 1 | $0 | $0 | $0 | $0 |
| Jeffrey M Spieler | Trustee | 1 | $0 | $0 | $0 | $0 |
| Jonathan Kagan | Trustee | 1 | $0 | $0 | $0 | $0 |
| Jonathan Shakes | Trustee | 1 | $0 | $0 | $0 | $0 |
| Kaye Wellings | Trustee | 1 | $0 | $0 | $0 | $0 |
| Manoj Gopalakrishna | Trustee | 1 | $0 | $0 | $0 | $0 |
| Mina Gerowin | Trustee | 1 | $0 | $0 | $0 | $0 |
| Nyovani Madise | Vice Chair Of The Board | 1 | $0 | $0 | $0 | $0 |
| Pape Gaye | Trustee | 1 | $0 | $0 | $0 | $0 |
| Parfait Eloundou-Enyegue | Trustee | 1 | $0 | $0 | $0 | $0 |
| Wanda Olson | Trustee | 1 | $0 | $0 | $0 | $0 |
Edith Asibey
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Elizabeth Abrams
Trustee (beg 09/2024)
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Fransje Van Der Waals
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Georgina Caswell
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Indre Rockefeller
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Jeffrey M Spieler
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Jonathan Kagan
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Jonathan Shakes
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Kaye Wellings
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Manoj Gopalakrishna
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Mina Gerowin
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Nyovani Madise
Vice Chair Of The Board
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Pape Gaye
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Parfait Eloundou-Enyegue
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0
Wanda Olson
Trustee
$0
Hrs/Wk
1
Compensation
$0
Related Orgs
$0
Other
$0